Role of CYP1A1 (T6235C) polymorphism and cigarette smoking in the development of coronary heart disease in Tunisian population

Journal of Genetics

Volumn 90, Issue 2, 2011, Pages 303-307

  Achour, Amani ^a   Zaag, Amani ^a   Gueddah, Latifa ^a   Trimeche, Besma ^b   Slama, Foued Ben Hadj ^a   Zemni, Ramzi ^a  

^a UNIVERSITY OF SOUSSE   (Tunisia)

^b FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

arachidonic acid; cigarette smoking; coronary artery disease; cytochrome P4501A1; genetic polymorphism

Indexed keywords

CYTOCHROME P450 1A1;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MIDDLE AGED; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TUNISIA;

ADULT; AGED; CONFIDENCE INTERVALS; CYTOCHROME P-450 CYP1A1; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING; TUNISIA;

EID: 80053132026     PISSN: 00221333     EISSN: 09737731     Source Type: Journal    
DOI: 10.1007/s12041-011-0058-x     Document Type: Article

References (16)

1. Bu R., Gutierrez M. I., Al-Rasheed M., Belgaumi A. and Bhatia K. 2004 Variable drug metabolism genes in Arab population. Pharmacogenomics J. 4, 260-266.
2. Cornelis M. C., El-Sohemy A. and Campos H. 2004 Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction. J. Med. Genet. 41, 758-762.
3. Cote M. L., Wenzlaff A. S., Bock C. H., Land S. J., Santer S. K., Schwartz D. R. et al. 2007 Combinations of cytochrome p-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study. Lung Cancer55, 255-262.
4. Garte S., Gaspari L., Alexandrie A. K., Ambrosone C., Autrup H., Autrup J. L. et al. 2001 Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prevent10, 1239-1248.
5. Jacquet M., Lambert V., Baudoux E., Muller M., Kremers P. and Gielen J. 1996 Correlation between P450 CYPlAl inducibility, MspI genotype and lung cancer incidence. Eur. J. Cancer32, 1701-1706.
6. Lee K. M., Kang D., Clapper M. L., Ingelman-Sundberg M., Ono-Kihara M., Kiyohara C. et al. 2008 CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations. Cancer Epidemiol. Biomarkers Prevent17, 1120-1126.
7. Manfredi S., Federici C., Picano E., Botto N., Rizza A. and Andreassi M. G. 2007 GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: A case-only study. Mutat. Res. 621, 106-112.
8. Ming L. I., Tong-yu G., Yao L. I. and Yan-qun N. A. 2008 Polymorphisms of GSTM1 and CYP1A1 genes and their genetic susceptibility to prostate cancer in Chinese men. Chin. Med. J. 121, 305-308.
9. Qiang M. A. and Lu A. Y. H. 2007 CYP1A induction and human risk assessment: an evolving tale of in vitro and in vivo studies. Drug Metab. Dispos. 35, 1009-1016.
10. Ramos K. S. and Moorthy B. 2005 Bioactivation of polycyclic aromatic hydrocarbon carcinogens within the vascular wall: implications for human atherogenesis. Drug Metab. Rev. 37, 595-610.
11. Schwarz D., Kisselev P., Ericksen S. S., Szklarz G. D., Chernogolov A., Honeck H. et al. 2004 Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(r), 18(s)-epoxyeicosatetraenoic acid. Biochem. Pharmacol. 67, 1445-1457.
12. Wang X. L., Greco M., Sim A. S., Duarte N., Wang J. and Wilcken D. E. L. 2002 Effect of CYP1A1 MspI polymorphism on cigarette smoking related coronary artery disease and diabetes. Atherosclerosis162, 391-397.
13. Wang X. L., Raveendran M. and Wang J. 2003 Genetic influence on cigarette-induced cardiovascular disease. Prog. Cardiovasc. Dis. 45, 361-382.
14. World Health Organisation 2008 The top ten causes of death. Fact Sheet 310. http://www. who. int/entity/mediacentre/factsheets/fs310_2008. pdf.
15. Yeh C. C., Sung F. C., Kuo L. T., Hsu W. P. and Chu H. Y. 2009 Polymorphisms of cytochrome P450 1A1, cigarette smoking and risk of coronary artery disease. Mutat. Res. 667, 77-81.
16. Zordoky B. N. M. and El-Kadi A. O. S. 2010 Effect of cytochrome P450 on arachidonic acid metabolism and their impact on cardiovascular diseases. Pharmacol. Ther. 125, 446-463.